Ladenburg Thalmann Financial Services’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$9K	Buy	181 +139	+331%	+$6.88K	﹤0.01%	4567
2019 Q3	$2K	Hold	42	–	–	﹤0.01%	5067
2019 Q2	$2K	Buy	42 +15	+56%	+$846	﹤0.01%	5061
2019 Q1	$1K	Sell	27 -1	-4%	-$43	﹤0.01%	5191
2018 Q4	$1K	Hold	28	–	–	﹤0.01%	5183
2018 Q3	$1K	Sell	28 -5	-15%	-$184	﹤0.01%	5122
2018 Q2	$1K	Hold	33	–	–	﹤0.01%	5087
2018 Q1	$1K	Hold	33	–	–	﹤0.01%	5087
2017 Q4	$1K	Hold	33	–	–	﹤0.01%	5011
2017 Q3	$1K	Hold	33	–	–	﹤0.01%	4910
2017 Q2	$1K	Buy	+33	New	+$760	﹤0.01%	4853

Other funds holding BHVN

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ladenburg Thalmann Financial Services's BHVN Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Biohaven Pharmaceutical Holding Company Ltd. (BHVN) stake by 331% in Q4 2019, buying an estimated $6.88K and bringing the position to 181 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #4567.

Ladenburg Thalmann Financial Services first reported a position in BHVN in Q2 2017 and has held it in 11 quarters since. 188 funds tracked by Wall St. Rank hold BHVN as of Q4 2019.

Ladenburg Thalmann Financial Services held 181 shares of Biohaven Pharmaceutical Holding Company Ltd. worth $9K as of Q4 2019.
Ladenburg Thalmann Financial Services bought 139 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2019, an estimated $6.88K.
Biohaven Pharmaceutical Holding Company Ltd. made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4567 holding.
Ladenburg Thalmann Financial Services first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2017 and has held it in 11 quarters since.
188 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.